• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SRX Global Announces Share Consolidation

    6/24/26 7:45:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $SRXH alert in real time by email

    NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the "Share Consolidation"), to be effective July 6, 2026 (the "Effective Date").

    On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol "SRXH" and will begin trading on a consolidated basis under a new CUSIP number at market open on the Effective Date. No fractional shares will be issued in connection with the Share Consolidation; any shareholder who would otherwise be entitled to a fractional share will receive one whole share in lieu thereof.

    About SRX Global Inc.

    SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the Share Consolidation, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

    Company Contact

    SRX Global

    Kent Cunningham, Chief Executive Officer

    Investor Relations Contact

    KCSA Strategic Communications

    Valter Pinto, Managing Director

    212-896-1254

    srx@kcsa.com



    Primary Logo

    Get the next $SRXH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRXH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SRX Global Announces Share Consolidation

    NORTH PALM BEACH, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that its Board of Directors has approved a consolidation of the Company's issued and outstanding common stock on a 60-to-1 basis (the "Share Consolidation"), to be effective July 6, 2026 (the "Effective Date"). On the Effective Date, every 60 shares of issued and outstanding common stock will be automatically combined into one share of common stock. The Company's common stock will continue to trade on the NYSE American under the existing symbol "SRXH" a

    6/24/26 7:45:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences

    NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl. ARMR’s lead product, ARMR-100, recently announced it has successfully generated an anti-fentanyl immune response in humans and showed favorable safety data. This marks a critical milestone in the company's path toward demonstrating that this response can protect against fentanyl. ARMR-100 is being designed to work with the body to generate a protective immune response. The product, in a Phase 1/2

    6/23/26 8:20:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets

    Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

    6/18/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    SEC Filings

    View All

    SEC Form DEFR14C filed by SRX Health Solutions Inc.

    DEFR14C - SRX Global Inc. (0001471727) (Filer)

    6/24/26 12:09:36 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    6/18/26 1:48:57 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 10-Q filed by SRX Health Solutions Inc.

    10-Q - SRx Health Solutions, Inc. (0001471727) (Filer)

    5/14/26 4:06:13 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

    TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

    10/1/25 8:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets

    Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

    6/18/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)

    NORTH PALM BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring 4.99% of Smartkem, Inc. (NASDAQ:SMTK), a leader in advanced materials, through a shelf take down. In conjunction with the 4.99% of equity, the Company has also purchased convertible preferred securities through a non-brokered private placement. Additional Information and Where to Find It In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on F

    6/8/26 12:07:43 PM ET
    $SMTK
    $SRXH
    Semiconductors
    Technology
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies

    NORTH PALM BEACH, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced board approval to dividend 75% of profits from investment in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV), with investments in SpaceX and other artificial intelligence and space companies. The Company recently announced an investment of greater than 10% of its investable capital in Astro Investment XVII and will return capital to shareholders upon wind down of the SPV. F

    5/15/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cunningham Kent Douglas

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:04:57 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 3 filed by new insider Cunningham Kent Douglas

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:01:45 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Conway Simon Alexander Malcolm

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 8:29:22 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples